(Q57571606)
Statements
Phase II study of raltitrexed (‘Tomudex’) for patients with advanced soft tissue sarcomas refractory to doxorubicin-containing regimens (English)
0 references
November 1999
0 references
10
0 references
10
0 references
873-878
0 references